Both in Pharmaceuticals
ABVC BioPharma vs Celularity
Over the past year ABVC returned −64.2% and CELU returned −56.9%; their daily moves had a correlation of 0.15.
ABVC −64.2% CELU −56.9%Growth of $1, one year, split-adjusted
| Metric | ABVC | CELU |
|---|---|---|
| Price | $1.01 | $0.8155 |
| Market cap | $27.0M | $26.5M |
| Today | −2.88% | −3.98% |
| 1 month | −1.0% | −40.9% |
| 6 months | −1.9% | −14.8% |
| Year to date | −52.6% | −26.5% |
| 1 year | −63.5% | −57.7% |
| Revenue growth (YoY) | — | −5.3% |
| Gross margin | — | 56.8% |
| Net margin | — | 10.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.4× |
| Net cash | $34.9K | -$37.1M |
| Dividend yield | — | — |
| Volatility (60d) | 79.0% | 223.0% |
| Short % of float | 2.7% | 6.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).